NCCS Cancer Policy Roundtable

The Cancer Policy Roundtable (CPR) is a semi-annual meeting convening stakeholders in the cancer community. Participants discuss pressing issues related to cancer research, development of new cancer therapies, and the delivery of quality cancer care.

The Spring 2020 CPR meeting took place virtually on March 26, 2020 via GoToWebinar, rather than in person. We had informative discussions on coronavirus’ impact on cancer survivors, end-of-life care for cancer patients, cancer rehabilitation, and Medicare payment models for cancer care. Watch the session recordings and find background info on the page linked below.

Virtual Cancer Policy Roundtable Page »

The Fall 2020 CPR meeting is scheduled for November 19. Read a summary of the Fall 2019 CPR meeting here [PDF].

CPR presenters range from public and health policy experts to representatives of the National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), Congressional health policy advisors and leaders in health insurance, pharmaceutical, and biotechnology industries.

These meetings are a great opportunity for interested parties to come together and discuss timely and compelling issues. Specific objectives and outcomes are unique to each meeting, however past meetings have focused on topics such as clinical trials, issues for older adults, expanded access programs, Medicare reimbursement, health care reform and other relevant topics.

For information on how to become a participant of this event, please contact us.

Fall 2019 Cancer Policy Roundtable Summary

Read or download the summary in a separate window » [PDF]

Spring 2019 Cancer Policy Roundtable Summary

Spring 2019 Cancer Policy Roundtable Summary

Read or download the summary in a separate window » [PDF]

Click to expand.

Otis Brawley, MD at CPR Spring 2018

CPR Spring 2018 Meeting: Otis Brawley, MD, then-CMO of the American Cancer Society, participates in a panel discussion about Overtreament and Overdiagnosis.


Cancer Policy Roundtable Sponsors

AbbVie Inc.
Bristol-Myers Squibb
Eisai Co.
Eli Lilly and Company
Genentech
Jazz Pharmaceuticals
Merck & Co. Inc.
MorphoSys AG
Novartis
Pfizer
PhRMA

(as of 3/18/2020)